Anti-B7-H3 CAR-T Cell Therapy

B7-H3-targeted CAR-T cell therapy · Beijing Tiantan Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-B7-H3 CAR-T Cell Therapy, covering 2025-02-11 to 2025-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma [Phase 1]